Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of lactobacillus gasseri SBT2055

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 1, 2012, Pages 66-71

  Kadooka, Yukio ^a   Tominari, Kazue ^b   Sakai, Fumihiko ^a   Yasui, Hisako ^b  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

breast milk; immunoglobulin A; mouse model; rotavirus; Tolllike receptor

Indexed keywords

IMMUNOGLOBULIN A; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST MILK; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; LACTOBACILLUS GASSERI; MALE; MATING; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SPLEEN CELL;

ANIMAL FEED; ANIMALS; CELLS, CULTURED; DIARRHEA; FECES; FEMALE; IMMUNOGLOBULIN A; LACTOBACILLUS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MILK; PEYER'S PATCHES; ROTAVIRUS; ROTAVIRUS INFECTIONS; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

LACTOBACILLUS GASSERI; MUS; ROTAVIRUS; SIMIAE;

EID: 84862325278     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182533a2b     Document Type: Article

References (39)

1. Widdowson MA, Bresee JS, Gentsch JR, et al. Rotavirus disease and its prevention. Curr Opin Gastroenterol 2005;21:26-31.
2. Gray J, Vesikari T, Van Damme P, et al. Rotavirus. J Pediatr Gastroenterol Nutr 2008;46:S24-31.
3. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
4. Parashar UD, Gibson CJ, Bresse JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-6.
5. Phua KB, Emmanuel SC, Goh P, et al. A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore 2006;35:38-44.
6. Velazquez FR. Protective effects of natural rotavirus infection. Pediatr Infect Dis J 2009;28:S54-6.
7. Mrukowicz J, Szajewska H, Vesikari T. Options for the prevention of rotavirus disease other than vaccination. J Pediatr Gastroenterol Nutr 2008;46:S32-7.
8. Bailey M, Haverson K, Inman C, et al. The development of the mucosal immune system pre- and post-weaning: balancing regulatory and effector function. Proc Nutr Soc 2005;64:451-7.
9. Kallewaard NL, McKinney BA, Gu Y, et al. Functional maturation of the human antibody response to rotavirus. J Immunol 2008;180:3980-9.
10. Hjelt K, Grauballe PC, Nielsen OH, et al. Rotavirus antibodies in the mother and her breast-fed infant. J Pediatr Gastroenterol Nutr 1985;4:414-20.
11. Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002;35:527-31.
12. Feng N, Franco MA, Greenberg HB. Murine model of rotavirus infection. Adv Exp Med Biol 1997;412:233-40.
13. Asensi MT, Martinez-Costa C, Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatr Gastroenterol Nutr 2006;42:560-7.
14. Rahman MM, Yamauchi M, Hanada N, et al. Local production of rotavirus specific IgA in breast tissue and transfer to neonates. Arch Dis Child 1987;62:401-5.
15. Sanz Y, De Palma G. Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 2009;28:397-413.
16. Yasui H, Kiyoshima J, Ushijima H. Passive protection against rotavirusinduced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J Infect Dis 1995;172:403-9.
17. Qiao H, Duffy LC, Griffiths E, et al. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 2002;51:750-5.
18. Guerin-Danan C, Meslin JC, Chambard A, et al. Food supplementation with milk fermented by Lactobacillus caseiDN-114 001 protects suckling rats from rotavirus-associated diarrhea. J Nutr 2001;131:111-7.
19. Pant N, Marcotte H, Brussow H, et al. Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 2007;7:86.
20. Usman, Hosono A. Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci 1999;82:243-8.
21. Fujiwara S, Seto Y, Kimura A, et al. Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 2001;90:343-52.
22. Takahashi H, Fujita T, Suzuki Y, et al. Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 2006;50:867-70.
23. Sato M, Uzu K, Yoshida T, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 2008;99:1013-7.
24. Kadooka Y, Ogawa A, Ikuyama K, et al. The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats. Int Dairy J 2011;21:623-7.
25. Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tenDencies in a randomized controlled trial. Eur J Clin Nutr 2010;64:636-43.
26. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr 2005;135:1294-8.
27. Santosa S, Farnworth E, Jones PJ. Probiotics and their potential health claims. Nutr Rev 2006;64:265-74.
28. Ng SC, Hart AL, Kamm MA, et al. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009;15:300-10.
29. Yasui H, Mike A, Ohwaki M. Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration. J Dairy Sci 1989;72:30-5.
30. Holmes IH. Reoviridae: the rotaviruses. In: Lennette EH, Halonen P, Murphy FA, eds. Laboratory Diagnosis-Principles and Practice Viral, Rickettsial and Chlamydial Disease. New York: Springer-Verlag; 1988:384-413.
31. Offit PA, Clark HF, Kornstein MJ, et al. A murine model for oral infection with a primate rotavirus (simian SA11). J Virol 1984;51:233-6.
32. Majerowicz S, Kubelka CF, Stephens P, et al. Ultrastructural study on experimental infection of rotavirus in a murine heterologous model. Mem Inst Oswaldo Cruz 1994;89:395-402.
33. Kubelka CF, Marchevsky RS, Stephens PR, et al. Murine experimental infection with rotavirus SA-11: clinical and immunohistological characteristics. Exp Toxicol Pathol 1994;45:433-8.
34. Ciarlet M, Ludert JE, Iturriza-Gomara M, et al. Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol 2002;76:4087-95.
35. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
36. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-51.
37. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004;200:805-9.
38. Morteau O, Gerard C, Lu B, et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol 2008;181:6309-15.
39. Liang Y, Hasturk H, Elliot J, et al. Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin Immunol 2011;138:33-40.